Technology News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Calvin Roberts, MD, program manager at the Advanced Research Projects Agency for Health, discusses two “moonshot” ophthalmology programs from the organization.

The Bascom Palmer Eye Institute at University of Miami Miller School of Medicine has received $4.7 million from NIH to create imaging techniques that will detect changes in capillary function and help diagnose cerebral small vessel disease.

Eschenbach Optik of America has launched Optaro, an attachable video magnifier designed for use with an iPhone to aid those with vision impairment, the company announced in a press release.

September is Healthy Aging Month, which the National Institute on Aging has celebrated by highlighting scientific innovations that help older adults remain independent as they age.

Since entering the market in 2011 as a treatment for meibomian gland dysfunction, the LipiFlow Thermal Pulsation System has consistently demonstrated its efficacy, according to a 15-year review published in Ophthalmology and Therapy.

LAS VEGAS — Virtual Vision Health released an enhanced user interface for its Virtual Eye Device, the company announced at Vision Expo West.

LAS VEGAS — Zenni Optical launched the VR Vision Screener, meant to complement a comprehensive eye exam, at Vision Expo West

LAS VEGAS — CSI Dry Eye Software has launched new technology that uses AI to assist clinicians in making a dry eye diagnosis and developing a treatment plan, according to a company executive at Vision Expo West.

Mobile apps can accurately mimic paper-based visual function tests, allowing key visual metrics to be evaluated at home, but clinicians must validate an app before using it for clinical management, according to a study published in Eye.

Patients with amblyopia who were treated with the CureSight eye-tracking system achieved greater improvement in visual acuity at week 16 vs. those treated with patching, according to a study published in American Journal of Ophthalmology.